Skip to content
Home
Technology
The platform
Artificial Intelligence
BioClick
Nobel Prize heritage
Biosolution phases
Scientific papers
Patents
Pipeline
Pipeline overview
NCT: Over-the-Counter
NCT: Pharma
Cannabinoids
Santalene
Become a partner
Investors
Stock information
News
Email signup
Investor Relation Contacts
Governance
SEC Filings
Video
About
Leadership team
History
Jobs
Policies
Terms of Use
FCOI
Privacy Policy
Contact
News
Latest news
Media coverage
Investor news
News archive
Homepage
Open navigation
Home
Technology
The platform
Artificial Intelligence
BioClick
Nobel Prize heritage
Biosolution phases
Scientific papers
Patents
Pipeline
Pipeline overview
NCT: Over-the-Counter
NCT: Pharma
Cannabinoids
Santalene
Become a partner
Investors
Stock information
News
Email signup
Investor Relation Contacts
Governance
SEC Filings
Video
About
Leadership team
History
Jobs
Policies
Terms of Use
FCOI
Privacy Policy
Contact
News
Latest news
Media coverage
Investor news
News archive
Posts in: perriman (2)
investor
nutraceuticals
medicine
press clippings
video
perriman
NCT
Nasdaq: Damien Perriman interview on NCT
April 2, 2026
investor
nutraceuticals
medicine
perriman
NCT
EXOZ investor update: eXoZymes de-risks scale-up with Cayman Chemical, validating tech transfer with pharma-grade output
March 18, 2026
press release
nutraceuticals
medicine
video
perriman
NCT
Video interview: Successful pilot scale run with Cayman Chemical validates eXoZymes' technology and scalability
March 18, 2026
press release
nutraceuticals
medicine
perriman
NCT
eXoZymes’ CCO Damien Perriman to Present a NCT solution at next week’s MISTA Symposium
March 12, 2026
nutraceuticals
medicine
press clippings
perriman
NCT
Vanity Fair: Inside NCTx - How A Rare Plant-Derived Molecule Is Turning Fat Into A Boost Of Energy
November 26, 2025
press release
science
perriman
Driving the cell-free revolution: eXoZymes leaders join BioMADE Leadership & Technical Committees
September 30, 2025
press release
investor
nutraceuticals
video
science
ARCHIVE
perriman
korman
ARCHIVE: eXoZymes details biomanufacturing breakthrough: 4 grams of NCT with over 99% purity
July 29, 2025
press clippings
video
ARCHIVE
perriman
ARCHIVE: World Bio Markets - AI and Machine Learning - The Silver Bullet we Must Not Dodge
July 2, 2025
investor
press clippings
video
ARCHIVE
perriman
ARCHIVE: Slack Capital interview: Damien Perriman, CCO
May 20, 2025
investor
press clippings
ARCHIVE
perriman
ARCHIVE: World Bio Market Insights: eXoZymes appoints Damien Perriman as Chief Commercial Officer
April 3, 2025
Previous page
Page 2 of 3
Next page